Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.60 |
| ▸ | HSD17B3 | P37058 | 7/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | STS | P08842 | 4/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30182775 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL29406518 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL222170 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL10595067 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL29623899 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL31751243 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL10594259 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL220528 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL82454 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL9087168 | 1.00 | KAT8 (0.60) | KAT8HSD17B3HTTFFAR1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144729-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4611719-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2025-09-10 | — | — | EP | claimed |
| WO-2024092386-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2024-05-10 | — | — | WO | claimed |
| US-8974804-B2 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2015-03-10 | — | — | US | claimed |
| US-20120301414-A1 | COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION AND USES THEREOF | L'OREAL (FR) | 2012-11-29 | — | — | US | claimed |
| EP-1415645-B1 | Composition in the form of an oil-in-water emulsion and its cosmetic uses | OREAL (FR) | 2007-10-03 | — | — | EP | claimed |
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2004-08-26 | — | — | US | claimed |
| US-20260144729-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2026-05-28 | — | — | US | disclosed |
| EP-4611719-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024092386-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2024-05-10 | — | — | WO | disclosed |
| US-20240115469-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2024-04-11 | — | — | US | disclosed |
| EP-4271356-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2023-11-08 | — | — | EP | disclosed |
| WO-2022118978-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2022-06-09 | — | — | WO | disclosed |
| US-20100256100-A1 | ROLL-ON WITH HIGH SALICYLIC ACID CONTENT | L'OREAL (FR) | 2010-10-07 | — | — | US | disclosed |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | L'OREAL (FR) | 2010-06-10 | — | — | US | disclosed |
| US-20090285868-A1 | Photostable cosmetic compositions comprising dibenzoylmethane/pyrrolidinone compounds | L'OREAL (FR) | 2009-11-19 | — | — | US | disclosed |
| US-20090029928-A1 | PEELING PROCESS AND COMPOSITION | L'OREAL (FR) | 2009-01-29 | — | — | US | disclosed |
| WO-2008064979-A2 | COSMETIC COMPOSITIONS CONTAINING A SILOXANE- CONTAINING ARYLALKYL BENZOATE AMIDE DERIVATIVE; USE OF SAID DERIVATIVE AS SOLVENT IN OILS; NOVEL SILOXANE- CONTAINING ARYLALKYL BENZOATE AMIDE DERIVATIVES | L'OREAL (FR) | 2008-06-05 | — | — | WO | disclosed |
| US-20070276044-A1 | Peeling Cosmetic Method Using a 8-Hexadecene-1,16-Dicarboxylic Acid | L'OREAL (FR) | 2007-11-29 | — | — | US | disclosed |
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256100-A1 | ROLL-ON WITH HIGH SALICYLIC ACID CONTENT | SUCLG1, CUTA, SYVN1 | KAT8 1122/4885HSD17B3 1878/4885HTT 2409/4885 |
| US-20070276044-A1 | Peeling Cosmetic Method Using a 8-Hexadecene-1,16-Dicarboxylic Acid | CUTA, RARA, RARG | KAT8 103/4885HSD17B3 1954/4885HTT 2221/4885 |
| US-20090029928-A1 | PEELING PROCESS AND COMPOSITION | CUTA, PRKCH, EBP | KAT8 574/4885HSD17B3 160/4885HTT 972/4885 |
| US-20090285868-A1 | Photostable cosmetic compositions comprising dibenzoylmethane/pyrrolidinone compounds | NOTUM, CYP51A1, DHPS | KAT8 851/4885HSD17B3 1495/4885HTT 1234/4885 |
| US-20120301414-A1 | COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION AND USES THEREOF | PLOD3, CUTA, LOXL1 | KAT8 1397/4885HSD17B3 1183/4885HTT 636/4885 |
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | PLOD3, CUTA, LOXL1 | KAT8 1397/4885HSD17B3 1183/4885HTT 636/4885 |
| US-20260144729-A1 | A CLEANSING COMPOSITION | SMURF1, CUTA, S100B | KAT8 1409/4885HSD17B3 167/4885HTT 271/4885 |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | FASN, ALOX12, PAH | KAT8 1835/4885HSD17B3 624/4885HTT 3261/4885 |
| US-20240115469-A1 | COMPOSITION FOR KERATIN FIBERS | KRT18, COL14A1, KIF5C | KAT8 909/4885HSD17B3 546/4885HTT 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.